Unibios Holdings S.A. (ATH:BIOSK)
Greece · Delayed Price · Currency is EUR 2.100
-0.070 (-3.23%)
Oct 13, 2026, 5:10 PM EET
Unibios Holdings Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 15.16 | 13.89 | 14.72 | 12.98 | 11.24 | 8.48 | |
Revenue Growth | -0.92% | -5.62% | 13.41% | 15.41% | 32.63% | 16.14% |
Cost of Revenue | 8.97 | 7.99 | 8.85 | 8.09 | 7.05 | 5.36 |
Gross Profit | 6.2 | 5.91 | 5.87 | 4.89 | 4.19 | 3.12 |
Selling, General & Admin | 5.41 | 4.28 | 3.5 | 3.05 | 2.95 | 2.51 |
Research & Development | - | - | 0.12 | 0.1 | - | - |
Other Operating Expenses | 0.1 | 0.24 | -0.1 | -0.07 | -0.09 | -0.12 |
Operating Expenses | 5.51 | 4.52 | 3.72 | 3.21 | 2.86 | 2.39 |
Operating Income | 0.69 | 1.39 | 2.15 | 1.68 | 1.34 | 0.72 |
Interest Expense | -0.33 | -0.34 | -0.35 | -0.62 | -0.39 | -0.37 |
Interest & Investment Income | 0.03 | 0.03 | 0.02 | 0 | 0 | 0 |
Currency Exchange Gain (Loss) | 0 | 0 | -0.02 | -0.02 | -0.04 | 0 |
Other Non Operating Income (Expenses) | - | - | -0 | -0 | - | - |
EBT Excluding Unusual Items | 0.39 | 1.08 | 1.79 | 1.04 | 0.9 | 0.35 |
Impairment of Goodwill | - | - | -0.4 | - | - | - |
Gain (Loss) on Sale of Assets | - | 1.07 | 0.03 | 1.33 | 0.03 | 0.02 |
Other Unusual Items | 0.08 | 0.08 | 0.13 | 0.03 | 0.06 | 0.18 |
Pretax Income | 0.47 | 2.23 | 1.55 | 2.4 | 1 | 0.55 |
Income Tax Expense | 0.5 | 0.73 | 0.53 | 0.37 | 0.35 | 0.22 |
Earnings From Continuing Operations | -0.04 | 1.49 | 1.03 | 2.03 | 0.65 | 0.33 |
Net Income to Company | -0.04 | 1.49 | 1.03 | 2.03 | 0.65 | 0.33 |
Minority Interest in Earnings | 0.18 | 0.18 | - | - | - | - |
Net Income | 0.14 | 1.67 | 1.03 | 2.03 | 0.65 | 0.33 |
Net Income to Common | 0.14 | 1.67 | 1.03 | 2.03 | 0.65 | 0.33 |
Net Income Growth | -94.08% | 62.70% | -49.40% | 211.71% | 94.85% | - |
Shares Outstanding (Basic) | 20 | 19 | 17 | 17 | 16 | 5 |
Shares Outstanding (Diluted) | 20 | 19 | 17 | 17 | 16 | 5 |
Shares Change | 13.06% | 15.05% | -0.87% | 6.87% | 204.21% | -67.88% |
EPS (Basic) | 0.01 | 0.09 | 0.06 | 0.12 | 0.04 | 0.06 |
EPS (Diluted) | 0.01 | 0.09 | 0.06 | 0.12 | 0.04 | 0.06 |
EPS Growth | -94.77% | 41.42% | -48.96% | 191.67% | -35.95% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -4.64 | -1.6 | -0.69 | 0.71 | -2.37 | 1.01 |
Free Cash Flow Per Share | -0.24 | -0.08 | -0.04 | 0.04 | -0.15 | 0.19 |
Gross Margin | 40.87% | 42.51% | 39.86% | 37.67% | 37.30% | 36.75% |
Operating Margin | 4.54% | 9.97% | 14.58% | 12.93% | 11.91% | 8.53% |
Profit Margin | 0.93% | 12.02% | 6.97% | 15.63% | 5.79% | 3.94% |
Free Cash Flow Margin | -30.60% | -11.55% | -4.66% | 5.48% | -21.06% | 11.92% |
EBITDA | 1.27 | 1.81 | 2.46 | 1.94 | 1.65 | 0.99 |
EBITDA Margin | 8.34% | 13.06% | 16.73% | 14.91% | 14.65% | 11.69% |
D&A For EBITDA | 0.58 | 0.43 | 0.32 | 0.26 | 0.31 | 0.27 |
EBIT | 0.69 | 1.39 | 2.15 | 1.68 | 1.34 | 0.72 |
EBIT Margin | 4.54% | 9.97% | 14.58% | 12.93% | 11.91% | 8.53% |
Effective Tax Rate | 107.57% | 32.93% | 33.88% | 15.58% | 34.79% | 39.47% |
Advertising Expenses | - | 0.04 | 0.05 | 0.02 | 0.06 | 0.01 |